Marston W A, Criado E, Jaques P F, Mauro M A, Burnham S J, Keagy B A
Department of Surgery, University of North Carolina at Chapel Hill School of Medicine 27599-7210, USA.
J Vasc Surg. 1997 Sep;26(3):373-80; discussion 380-1. doi: 10.1016/s0741-5214(97)70030-2.
Salvage of thrombosed prosthetic dialysis shunts can be performed using surgical or endovascular techniques. A prospective randomized trial was designed to compare the efficacy of these two methods in restoring dialysis access function.
One hundred fifteen patients with thrombosed dialysis shunts were randomized prospectively to surgical (n = 56) or endovascular (n = 59) therapy. In the surgical group, salvage was attempted with thrombectomy alone in 22% and with thrombectomy plus graft revision in 78%. In the endovascular group, graft function was restored with mechanical (82%) or thrombolytic (18%) graft thrombectomy followed by percutaneous angioplasty.
Stenosis limited to the venous anastomotic area was the cause of shunt thrombosis in 55% of patients, and long-segment venous outflow stenosis or occlusion was the cause in 30%. In 83% of the surgical group and in 72% of the endovascular group, graft function was immediately restored (p = NS). The postoperative graft function rate was significantly better in the surgical group (p < 0.05). Thirty-six percent of grafts managed surgically remained functional at 6 months and 25% at 12 months. In the endovascular group, 11% were functional at 6 months and 9% by 12 months. Patients with long-segment venous outflow stenosis or occlusion had a significantly worse patency rate than those with venous anastomotic stenosis (p < 0.05).
Neither surgical nor endovascular management resulted in long-term function for the majority of shunts after thrombosis. However, surgical management resulted in significantly longer primary patency in this patient population, supporting its use as the primary method of management in most patients in whom shunt thrombosis develops.
对于血栓形成的人工透析分流管,可采用外科手术或血管内技术进行挽救。设计了一项前瞻性随机试验,以比较这两种方法恢复透析通路功能的疗效。
115例血栓形成的透析分流管患者被前瞻性随机分为手术治疗组(n = 56)或血管内治疗组(n = 59)。手术组中,22%仅尝试进行血栓切除术,78%进行血栓切除术加移植物修复术。血管内治疗组中,通过机械性(82%)或溶栓性(18%)移植物血栓切除术,随后进行经皮血管成形术来恢复移植物功能。
55%的患者分流管血栓形成的原因是局限于静脉吻合口区域的狭窄,30%是长段静脉流出道狭窄或闭塞。手术组83%和血管内治疗组72%的移植物功能立即恢复(p = 无显著差异)。手术组术后移植物功能率显著更好(p < 0.05)。手术治疗的移植物在6个月时36%仍保持功能,12个月时25%仍保持功能。血管内治疗组中,6个月时11%保持功能,12个月时9%保持功能。长段静脉流出道狭窄或闭塞的患者通畅率明显低于静脉吻合口狭窄的患者(p < 0.05)。
血栓形成后,无论是外科手术还是血管内治疗,大多数分流管都无法实现长期功能。然而,手术治疗在该患者群体中导致的初次通畅时间明显更长,支持将其作为大多数发生分流管血栓形成患者的主要治疗方法。